梅斯医学APP升级,新增“积分明细”,“相互关注”诸多功能

2020-09-15 MedSci原创 MedSci原创

梅斯医学APP最新升级,增加了大量新的功能,更方便大家获取积分,使用积分。这些功能均在最新版的梅斯医学APP中:

梅斯医学APP最新升级,增加了大量新的功能,更方便大家获取积分,使用积分。这些功能均在最新版的梅斯医学APP中:

1 新增积分明细,明明白白知道积分的增加和减少,目前提供最近3个月的积分明细。

2 “同好圈”,通过同好圈,既可以给自己打标签(可以增加积分),还可以关注同好的朋友(也能增加积分)

3 赚积分:即做任务,可以做不同任务,均可以增加积分。

4 实名认证:在APP的“我”中,更方便进行认证

后面会进一步增加新的功能,下周会增加极为方便的“速录”功能,以后参加科室会议,外面学术会议,可以用梅斯医学APP,直接进行录音,并转化为文字了。

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1953097, encodeId=393e195309e44, content=<a href='/topic/show?id=7f5462434fd' target=_blank style='color:#2F92EE;'>#梅斯医学APP#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62434, encryptionId=7f5462434fd, topicName=梅斯医学APP)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f7c9348, createdName=neizongke, createdTime=Sun Mar 07 15:45:22 CST 2021, time=2021-03-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1277141, encodeId=b5d412e714103, content=<a href='/topic/show?id=bde16242956' target=_blank style='color:#2F92EE;'>#梅斯#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62429, encryptionId=bde16242956, topicName=梅斯)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=18fc139, createdName=一闲, createdTime=Thu Sep 17 13:45:22 CST 2020, time=2020-09-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=885661, encodeId=a5e88856619e, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=64245268311, createdName=14818eb4m67暂无昵称, createdTime=Wed Sep 16 08:18:32 CST 2020, time=2020-09-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=885588, encodeId=c0fe8855881b, content=<a href='/topic/show?id=148562431a3' target=_blank style='color:#2F92EE;'>#梅斯医学#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=168, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62431, encryptionId=148562431a3, topicName=梅斯医学)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=lovetcm, createdTime=Tue Sep 15 23:04:03 CST 2020, time=2020-09-15, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1953097, encodeId=393e195309e44, content=<a href='/topic/show?id=7f5462434fd' target=_blank style='color:#2F92EE;'>#梅斯医学APP#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62434, encryptionId=7f5462434fd, topicName=梅斯医学APP)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f7c9348, createdName=neizongke, createdTime=Sun Mar 07 15:45:22 CST 2021, time=2021-03-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1277141, encodeId=b5d412e714103, content=<a href='/topic/show?id=bde16242956' target=_blank style='color:#2F92EE;'>#梅斯#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62429, encryptionId=bde16242956, topicName=梅斯)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=18fc139, createdName=一闲, createdTime=Thu Sep 17 13:45:22 CST 2020, time=2020-09-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=885661, encodeId=a5e88856619e, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=64245268311, createdName=14818eb4m67暂无昵称, createdTime=Wed Sep 16 08:18:32 CST 2020, time=2020-09-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=885588, encodeId=c0fe8855881b, content=<a href='/topic/show?id=148562431a3' target=_blank style='color:#2F92EE;'>#梅斯医学#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=168, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62431, encryptionId=148562431a3, topicName=梅斯医学)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=lovetcm, createdTime=Tue Sep 15 23:04:03 CST 2020, time=2020-09-15, status=1, ipAttribution=)]
    2020-09-17 一闲
  3. [GetPortalCommentsPageByObjectIdResponse(id=1953097, encodeId=393e195309e44, content=<a href='/topic/show?id=7f5462434fd' target=_blank style='color:#2F92EE;'>#梅斯医学APP#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62434, encryptionId=7f5462434fd, topicName=梅斯医学APP)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f7c9348, createdName=neizongke, createdTime=Sun Mar 07 15:45:22 CST 2021, time=2021-03-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1277141, encodeId=b5d412e714103, content=<a href='/topic/show?id=bde16242956' target=_blank style='color:#2F92EE;'>#梅斯#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62429, encryptionId=bde16242956, topicName=梅斯)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=18fc139, createdName=一闲, createdTime=Thu Sep 17 13:45:22 CST 2020, time=2020-09-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=885661, encodeId=a5e88856619e, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=64245268311, createdName=14818eb4m67暂无昵称, createdTime=Wed Sep 16 08:18:32 CST 2020, time=2020-09-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=885588, encodeId=c0fe8855881b, content=<a href='/topic/show?id=148562431a3' target=_blank style='color:#2F92EE;'>#梅斯医学#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=168, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62431, encryptionId=148562431a3, topicName=梅斯医学)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=lovetcm, createdTime=Tue Sep 15 23:04:03 CST 2020, time=2020-09-15, status=1, ipAttribution=)]
    2020-09-16 14818eb4m67暂无昵称

    学习

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1953097, encodeId=393e195309e44, content=<a href='/topic/show?id=7f5462434fd' target=_blank style='color:#2F92EE;'>#梅斯医学APP#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62434, encryptionId=7f5462434fd, topicName=梅斯医学APP)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f7c9348, createdName=neizongke, createdTime=Sun Mar 07 15:45:22 CST 2021, time=2021-03-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1277141, encodeId=b5d412e714103, content=<a href='/topic/show?id=bde16242956' target=_blank style='color:#2F92EE;'>#梅斯#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62429, encryptionId=bde16242956, topicName=梅斯)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=18fc139, createdName=一闲, createdTime=Thu Sep 17 13:45:22 CST 2020, time=2020-09-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=885661, encodeId=a5e88856619e, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=64245268311, createdName=14818eb4m67暂无昵称, createdTime=Wed Sep 16 08:18:32 CST 2020, time=2020-09-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=885588, encodeId=c0fe8855881b, content=<a href='/topic/show?id=148562431a3' target=_blank style='color:#2F92EE;'>#梅斯医学#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=168, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62431, encryptionId=148562431a3, topicName=梅斯医学)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=lovetcm, createdTime=Tue Sep 15 23:04:03 CST 2020, time=2020-09-15, status=1, ipAttribution=)]

相关资讯

小调研:梅斯医学主站升级改版,倾听您的声音

梅斯医学主站https://www.medsci.cn 从5月22日上线以来,已经1个月了。此次开发是从底层完全改变,包括开发语言,也切换为JAVA语言。目前整体功能基本完善80%左右,在这个月期间,

梅斯医学:依托“互联网+医疗”双轮驱动,打造医企患深度数字化产品闭环

“我们希望最终实现‘改善医疗质量’的愿景。”

转载梅斯医学原创信息的原则与规范(第一版)

梅斯医学作为医学平台,一方面为不同用户和客户提供信息展示的窗口,另一方面,每天也产生大量的原创内容。为了为进一步保护原创网站的知识产权与辛勤付出,梅斯医学平台制订了相关规范,见《MedSci平台转载信

梅斯医学主站今天升级,更好支持手机端,支持用户阅读和信息发布

梅斯医学主站一直以清爽据称,已有多年未改变风格了。

MedSci积分调整公告(2021年2月修订)

在众多会员反映网站需要积分,实际上积分主要是希望大家参与到网站中来,只要参与网站就容易获得积分,这样积分就可以消费网站上一些服务,或一些消耗积分的内容。

“战疫情,用笔尖凝聚爱”——主题征文活动开始啦!

“战疫情,用笔尖凝聚爱”——梅斯医学线上主题征文活动开始啦!